 Central Nervous System Stimulants
"Central Nervous System Stimulants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here.
| Descriptor ID |
D000697
|
| MeSH Number(s) |
D27.505.696.282 D27.505.954.427.220
|
| Concept/Terms |
Analeptics- Analeptics
- Analeptic Drugs
- Drugs, Analeptic
- Analeptic Agents
- Agents, Analeptic
|
Below are MeSH descriptors whose meaning is more general than "Central Nervous System Stimulants".
Below are MeSH descriptors whose meaning is more specific than "Central Nervous System Stimulants".
This graph shows the total number of publications written about "Central Nervous System Stimulants" by people in this website by year, and whether "Central Nervous System Stimulants" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 0 | 2 | | 1997 | 1 | 0 | 1 | | 1998 | 1 | 1 | 2 | | 1999 | 3 | 0 | 3 | | 2000 | 1 | 0 | 1 | | 2001 | 1 | 0 | 1 | | 2003 | 1 | 1 | 2 | | 2004 | 5 | 3 | 8 | | 2005 | 1 | 2 | 3 | | 2006 | 2 | 3 | 5 | | 2007 | 6 | 3 | 9 | | 2008 | 2 | 2 | 4 | | 2009 | 7 | 2 | 9 | | 2010 | 4 | 0 | 4 | | 2011 | 7 | 3 | 10 | | 2012 | 5 | 3 | 8 | | 2013 | 4 | 2 | 6 | | 2014 | 2 | 2 | 4 | | 2015 | 4 | 1 | 5 | | 2016 | 4 | 3 | 7 | | 2017 | 3 | 1 | 4 | | 2018 | 5 | 2 | 7 | | 2019 | 3 | 0 | 3 | | 2020 | 5 | 0 | 5 | | 2021 | 3 | 0 | 3 | | 2022 | 3 | 0 | 3 | | 2023 | 3 | 0 | 3 | | 2024 | 1 | 2 | 3 | | 2025 | 5 | 0 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Central Nervous System Stimulants" by people in Profiles.
-
Strickland JC, Tilton HE, Patton NM, Vandrey R, Austin Zamarripa C, Spindle TR, Lee DC, Bergeria CL, Wolinsky D, Klawitter J, Sempio C, Campos-Palomino J, Christians U, Feldner MT, Irons JG, Bonn-Miller MO. Effect of caffeine and cannabidiol (CBD) co-administration on ?9-tetrahydrocannabinol (?9-THC) subjective effects, performance impairment, and pharmacokinetics. Neuropsychopharmacology. 2025 Nov; 50(12):1827-1835.
-
Falise AM, Sutphin A, Culbreth R, Aldy K, Burkhart K, Brent J, Campleman SL, Day H, Wills A, Krotulski A, Wax P. Detected substances among patients with confirmed bromazolam exposure who present to the emergency department following a suspected opioid and/or stimulant-related non-fatal overdose. Drug Alcohol Depend. 2025 Sep 01; 274:112776.
-
Cembellin-Kao A, Aldy K, Brent J, Culbreth R, LaBozzetta C, Turcios MA, Wax P, Yonamine C, Stolbach A. Occult bromazolam exposure in patients presenting with opioid or stimulant overdose. Clin Toxicol (Phila). 2025 May; 63(5):330-336.
-
Weisbrod LJ, Schmidt AJ, Tanabe J, Sakai J, Ojemann S, Pawlowski JR, Shiffermiller JF, Abosch A. Deep Brain Stimulation for Methamphetamine Use Disorder: Perioperative Neuropsychiatric and Other Medical Considerations. J Neuropsychiatry Clin Neurosci. 2025; 37(3):209-221.
-
Rios SM, Mootz JRK, Phillips TJ, Ingram SL. Absence of TAAR1 function increases methamphetamine-induced excitability of dorsal raphe serotonin neurons and drives binge-level methamphetamine intake. Neuropsychopharmacology. 2025 Jun; 50(7):1136-1144.
-
Barocas JA, Erdman EA, Westfall MY, Christine PJ, Bernson D, Villani J, Doogan NJ, White L, Walley AY, Bettano A, Wang J. Prevalence of adults with stimulant misuse and/or stimulant use disorder in Massachusetts, USA, 2014-2021. Addiction. 2025 Apr; 120(4):711-720.
-
Metcalf CA, Page CE, Stocker BOS, Johnson RL, Duffy KA, Sammel MD, Loughead J, Epperson CN. Treating new-onset cognitive complaints after risk-reducing salpingo-oophorectomy: A randomized controlled crossover trial of lisdexamfetamine. Gynecol Oncol. 2024 Nov; 190:62-69.
-
Friedman SL, Shults J, Barbaresi W, Bax A, Cacia J, Deavenport-Saman A, LaRosa A, Loe IM, Mittal S, Vanderbilt DL, Blum N, Harstad E. Attention-Deficit/Hyperactivity Disorder in Medication Treated Preschool-Age Children Without and With Autism Spectrum Disorder: A Developmental-Behavioral Research Network Study. J Dev Behav Pediatr. 2024 Jul-Aug 01; 45(4):e372-e377.
-
Camfield K, Reedy A, Wolf C, Al-Tayyib A, Rinehart D, Simpson SA. Diagnosis of methamphetamine-induced psychotic disorder: Findings of an expert consensus panel. Early Interv Psychiatry. 2024 Dec; 18(12):1015-1021.
-
Rockhill KM, Olson R, Dart RC, Iwanicki JL, Black JC. Differing Behaviors Around Adult Nonmedical Use of Prescription Stimulants and Opioids: Latent Class Analysis. J Med Internet Res. 2023 09 20; 25:e46742.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|